| scholarly article | Q13442814 |
| P50 | author | Concetta DiRusso | Q25324859 |
| Paul N. Black | Q56155401 | ||
| Craig W. Lindsley | Q67215429 | ||
| Constance Ahowesso | Q117207104 | ||
| David Montefusco | Q117207105 | ||
| P2093 | author name string | Shaun R Stauffer | |
| Nipun Saini | |||
| Chrysa Malosh | |||
| Jessica Chekal | |||
| P2860 | cites work | Human very long-chain acyl-CoA synthetase and two human homologs: initial characterization and relationship to fatty acid transport protein | Q22010504 |
| A family of fatty acid transporters conserved from mycobacterium to man | Q24681246 | ||
| A simple method for the isolation and purification of total lipides from animal tissues | Q25939009 | ||
| Dietary habits and behaviors associated with nonalcoholic fatty liver disease | Q26830594 | ||
| Disruption of the Saccharomyces cerevisiae homologue to the murine fatty acid transport protein impairs uptake and growth on long-chain fatty acids | Q27934119 | ||
| Identification of the major intestinal fatty acid transport protein | Q28145772 | ||
| Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins | Q28244789 | ||
| Targeted deletion of fatty acid transport protein-4 results in early embryonic lethality | Q28511574 | ||
| Fatty acid transport by vectorial acylation in mammals: roles played by different isoforms of rat long-chain acyl-CoA synthetases | Q28566986 | ||
| CD36 in myocytes channels fatty acids to a lipase-accessible triglyceride pool that is related to cell lipid and insulin responsiveness | Q28578805 | ||
| Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle | Q28586493 | ||
| Fatty acid transport protein 1 is required for nonshivering thermogenesis in brown adipose tissue | Q28587877 | ||
| FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity | Q28588041 | ||
| Mice deleted for fatty acid transport protein 5 have defective bile acid conjugation and are protected from obesity | Q28594092 | ||
| Lipid homeostasis, lipotoxicity and the metabolic syndrome. | Q30383031 | ||
| Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future | Q30597265 | ||
| Identification and characterization of small compound inhibitors of human FATP2 | Q33624437 | ||
| How are free fatty acids transported in membranes? Is it by proteins or by free diffusion through the lipids? | Q33783971 | ||
| Role of CD36 in membrane transport and utilization of long-chain fatty acids by different tissues | Q34322431 | ||
| Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein | Q34325172 | ||
| Mechanisms of lipoapoptosis: implications for human heart disease | Q34635665 | ||
| Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. | Q34655571 | ||
| Triglyceride accumulation protects against fatty acid-induced lipotoxicity | Q34866329 | ||
| A modified protocol to maximize differentiation of human preadipocytes and improve metabolic phenotypes. | Q35061663 | ||
| Lipotoxicity: when tissues overeat | Q35168828 | ||
| Human fatty acid transport protein 2a/very long chain acyl-CoA synthetase 1 (FATP2a/Acsvl1) has a preference in mediating the channeling of exogenous n-3 fatty acids into phosphatidylinositol | Q35182936 | ||
| Fatty acid transport proteins, implications in physiology and disease | Q35742713 | ||
| Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes | Q35923385 | ||
| Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis | Q35939383 | ||
| A novel mouse model of lipotoxic cardiomyopathy | Q36016938 | ||
| Overexpression of human fatty acid transport protein 2/very long chain acyl-CoA synthetase 1 (FATP2/Acsvl1) reveals distinct patterns of trafficking of exogenous fatty acids | Q36336502 | ||
| Cardiac lipotoxicity: molecular pathways and therapeutic implications | Q36824112 | ||
| Small molecule kaempferol modulates PDX-1 protein expression and subsequently promotes pancreatic β-cell survival and function via CREB. | Q36846424 | ||
| Initiation and execution of lipotoxic ER stress in pancreatic beta-cells | Q36910693 | ||
| Lipotoxic heart disease in obese rats: implications for human obesity | Q37117677 | ||
| Dietary fat in breast cancer survival | Q37368304 | ||
| Saturated with fat: new perspectives on lipotoxicity | Q37388367 | ||
| Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease | Q37405640 | ||
| Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal | Q37578517 | ||
| Palmitate-induced activation of mitochondrial metabolism promotes oxidative stress and apoptosis in H4IIEC3 rat hepatocytes | Q37625425 | ||
| Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity | Q37707665 | ||
| Oxidative stress and lipid peroxidation by-products at the crossroad between adipose organ dysregulation and obesity-linked insulin resistance | Q38070281 | ||
| Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches. | Q38121574 | ||
| New medications for obesity management: changing the landscape of obesity treatment | Q38131360 | ||
| Mechanisms of cellular uptake of free fatty acids | Q38677527 | ||
| Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis | Q39731721 | ||
| Palmitate induces insulin resistance without significant intracellular triglyceride accumulation in HepG2 cells | Q39764118 | ||
| Methods to monitor Fatty Acid transport proceeding through vectorial acylation | Q39794448 | ||
| Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes | Q39885259 | ||
| Design, synthesis, and characterization of new iron chelators with anti-proliferative activity: structure-activity relationships of novel thiohydrazone analogues. | Q40061650 | ||
| Identification and characterization of 4-aryl-3,4-dihydropyrimidin-2(1H)-ones as inhibitors of the fatty acid transporter FATP4. | Q40286683 | ||
| Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle | Q40334538 | ||
| Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. | Q40452210 | ||
| Differential impact of acute and chronic lipotoxicity on gene expression in INS-1 cells. | Q40752284 | ||
| Chronic effects of different fatty acids and leptin in INS-1 cells | Q40834794 | ||
| Peroxisome proliferator-activated receptor alpha (PPARalpha) protects against oleate-induced INS-1E beta cell dysfunction by preserving carbohydrate metabolism | Q42462866 | ||
| Arylpiperazines as fatty acid transport protein 1 (FATP1) inhibitors with improved potency and pharmacokinetic properties. | Q42712305 | ||
| Glucose Sensitivity and Metabolism-Secretion Coupling Studied during Two-Year Continuous Culture in INS-1E Insulinoma Cells | Q42798453 | ||
| Fatty acid transport and activation and the expression patterns of genes involved in fatty acid trafficking | Q42810966 | ||
| CD36 as a target to prevent cardiac lipotoxicity and insulin resistance | Q43500625 | ||
| Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover | Q43555581 | ||
| A live-cell high-throughput screening assay for identification of fatty acid uptake inhibitors. | Q50487193 | ||
| Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity | Q64377000 | ||
| Effect of the lipase inhibitor orlistat and of dietary lipid on the absorption of radiolabelled triolein, tri-γ-linolenin and tripalmitin in mice | Q71951883 | ||
| Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans | Q72223826 | ||
| Vectorial acylation: linking fatty acid transport and activation to metabolic trafficking | Q80685047 | ||
| Discovery and optimization of novel fatty acid transport protein 1 (FATP1) inhibitors | Q84504455 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fatty acid | Q61476 |
| cell death | Q2383867 | ||
| P304 | page(s) | 167-181 | |
| P577 | publication date | 2015-09-19 | |
| P1433 | published in | Biochemical Pharmacology | Q864229 |
| P1476 | title | Chemical inhibition of fatty acid absorption and cellular uptake limits lipotoxic cell death | |
| P478 | volume | 98 |
| Q89107815 | Adipocyte-Derived Lipids Mediate Melanoma Progression via FATP Proteins |
| Q90437105 | Deletion of Fatty Acid Transport Protein 2 (FATP2) in the mouse liver changes the metabolic landscape by increasing the expression of PPARα-regulated genes |
| Q50420689 | Developmental origins of non-alcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease. |
| Q37102291 | Fatty Acid Transport Proteins: Targeting FATP2 as a Gatekeeper Involved in the Transport of Exogenous Fatty Acids |
| Q93163644 | Fatty acid transport protein 2 reprograms neutrophils in cancer |
| Q60044667 | Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease |
| Q57297096 | Intestinal Saturated Long-Chain Fatty Acid, Glucose and Fructose Transporters and Their Inhibition by Natural Plant Extracts in Caco-2 Cells |
| Q102220205 | Involvement of FATP2-mediated tubular lipid metabolic reprogramming in renal fibrogenesis |
| Q92502767 | Mitochondrial fusion regulates lipid homeostasis and stem cell maintenance in the Drosophila testis |
| Q58548697 | Rosiglitazone ameliorates palmitic acid-induced cytotoxicity in TM4 Sertoli cells |
| Q42374211 | Sodium fluorocitrate having protective effect on palmitate-induced beta cell death improves hyperglycemia in diabetic db/db mice |
Search more.